Navigation Links
Speech disrupts facial attention in 6-month-olds who later develop autism
Date:2/4/2014

Philadelphia, PA, February 4, 2014 From birth, infants naturally show a preference for human contact and interaction, including faces and voices. These basic predispositions to social stimuli are altered in individuals diagnosed with autism spectrum disorders (ASD).

A new study published in Biological Psychiatry this week, from researchers at the Yale University School of Medicine, now reports that 6-month-old infants later diagnosed with autism divert their gaze from facial features when that face is speaking.

One of the best methods to examine autism in very young infants is the use of eye-tracking. This technology uses advanced video monitoring and special software that tracks and 'maps' exactly where the eyes were focused and for how long.

Dr. Frederick Shic and his colleagues used this method to examine how 6-month-old infants looked at videos of still, smiling, and speaking faces. The infants were later assessed at 3 years of age and divided into groups based on based on their diagnosis of ASD, other developmental delays, or typical development.

Infants who later developed ASD not only looked at all faces less than other infants, but also, when shown a face that was speaking, looked away from key facial features such as the eyes and mouth.

"These results suggest that the presence of speech disrupts typical attentional processing of faces in those infants later diagnosed with ASD," said Shic. "This is the first study to isolate an atypical response to speech as a specific characteristic in the first half year after birth that is associated with later emerging ASD."

These findings indicate that infants who later develop ASD have difficulty maintaining attention to relevant social information as early as 6 months of age, a phenomenon that could reduce the quality of their social and communicative exchanges with others and, consequently, the trajectory of their social development.

Autism typically can't be diagnosed until at least two years of age, but this and other studies confirm that abnormalities in behavior and attention can be detected as early as 6 months of age.

"It seems clear that brain changes related to autism appear much earlier than we traditionally diagnose this disorder," commented Dr. John Krystal, Editor of Biological Psychiatry. "This study elegantly illustrates that autism-related disturbances in social relatedness are present very early in life, shaping one's most fundamental social contacts."

These affected infants may be experiencing an altered social experience at a critical developmental point. The hope is that this and further research can help clarify how and when the developmental trajectory is altered in children who develop autism and, potentially, develop targeted interventions that could normalize their developmental processes.


'/>"/>

Contact: Rhiannon Bugno
Biol.Psych@utsouthwestern.edu
214-648-0880
Elsevier
Source:Eurekalert

Related medicine news :

1. Speech Recognition Solutions, LLC Launches New Website That Sets New Standard in Technical Support for Dragon Medical Practice Edition 2
2. ASHA Approved Continuing Education Provider Offering Deeper Discounts on Speech-Language Pathology Continuing Education Flex Packages.
3. ZyDoc Links Philips SpeechExec Enterprise to MediSapien Structured Reporting and Analytics for Radiology at RSNA 2013
4. Latest Research and Treatment Innovations in Speech, Language, and Hearing Disorders to be Presented at ASHA National Convention
5. LSUHSC bird study finds key info about human speech-language development
6. Speech4Me Providing Best-in-Class Support to Physicians That Speech-Enable Their EHR with Dragon Medical Practice Edition 2
7. Synthetic speech system puts a dampener on noisy announcements
8. ASHA Approved Continuing Education Provider Announces Schedule Of Live Speech-Language Pathology Webinars
9. MyVoice Releases “College Life Pack” for TalkRocket Go Speech Aid App
10. Inner speech speaks volumes about the brain
11. Dubai's Princess Haya Delivers Stirring Expo 2020 Speech in Paris
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Coffey Agencies, a ... and commercial clients in the northern Alabama and Georgia regions, is embarking on ... 1977, Nobis Works has built a network of support and education facilities to ...
(Date:12/7/2016)... , ... December 07, 2016 , ... DrugDev ... announcement that it is one of the early adopters completing EU-U.S. Privacy Shield Certification ... designed to provide companies on both sides of the Atlantic with a mechanism to ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... celebrating the passage of the most comprehensive mental health systems reform legislation in ... support of the President, and the commitment of our elected officials to improving ...
(Date:12/7/2016)... York, NY (PRWEB) , ... December 07, 2016 ... ... amounts of the drug in their bodies, a researcher at the Icahn School ... journal Pediatric Research. , The study found that when young children are exposed ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... of Smart Device Remote Control through a new partnership with Splashtop Inc. This ... strengthens its mobile solutions to help businesses maximize their uptime and productivity. , ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Henry Schein, Inc. (Nasdaq: ... care products and services to office-based dental, animal health and ... equity investment in Marrodent, one of Poland,s ... $32 million. This transaction was announced on August 30, 2016. ... Poland since 2014, and Marrodent marks ...
(Date:12/8/2016)... Dec 8, 2016 Research and Markets has announced ... report to their offering. ... , The report provides separate comprehensive ... , and Rest of World. Annual estimates and ... historic analysis is provided for these markets. Market data and analytics are ...
(Date:12/7/2016)... Dec. 7, 2016 "Lantus (Insulin Glargine) Biosimilar Clinical Trial & ... biosimilar version of Lantus drug in clinical pipeline. Currently 5 biosimilar version ... Japan , Kenya , Czech ... , China , Slovakia , ... 2 diabetes mellitus. The patent on Lantus expired in 2014. Lantus ...
Breaking Medicine Technology: